Skip to main content

Dispute Within CDC Over Zika Testing

An agency scientist who accused the Centers for Disease Control and Prevention of suppressing disagreements over the accuracy of a diagnostic test obtains whistleblower protection.

Written byBen Andrew Henry
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FLICKR, NIAID

Federal documents released to the public this week (September 27) reveal an ongoing dispute within the US Centers for Disease Control and Prevention (CDC) over how to screen for Zika virus infection, as first reported by The Washington Post. According to the Washington Post, the agency demoted a top researcher in May who had accused the CDC of withholding evidence from state and local laboratories, suggesting that current tests are less effective than alternative ones, then later reinstated his position after he invoked legal protection as a whistleblower.

News of the conflict came to light after the Office of Special Counsel (which handles whistleblower complaints) released documents containing an intra-CDC investigation on the matter.

The dispute began last spring, the documents show, when the public ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays